Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Atomwise Signs Strategic Multi-Target Research Collaboration with Sanofi for AI-Powered Drug Discovery
Atomwise, a leader in using artificial intelligence (AI) for small molecule drug discovery, today announced […]
Rocket VR Health Partners with Penn Medicine's Abramson Cancer Center to Study the Use of VR in Patients Undergoing Radiation Therapy
Rocket VR Health, a digital therapeutics company developing immersive therapy programs, is partnering with Penn Medicine’s […]
Standigm Names Carl Foster Chief Business Officer to Expand Strategic Partnerships for AI Drug Discovery
Standigm Inc. (“Standigm”), the leading workflow artificial intelligence (AI) drug discovery company, today announced the appointment […]
Trial Library Emerges Out of Stealth with $5 Million in Seed Funding, Led by Lux Capital
Trial Library, Inc., an oncology clinical trials company, today announced it has come out of […]
Karkinos Healthcare Engages OptraSCAN® Digital Pathology In its Mission of Personalized Cancer Care
OptraSCAN®, a leading end-to-end digital pathology solution provider, today announced that Karkinos Healthcare has begun using the […]
PAN-TB Collaboration to Advance Investigational Tuberculosis Drug Regimens to Phase 2 Clinical Trials
The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) collaboration announced today the execution of […]
Medicines and Healthcare Products Regulatory Agency (MHRA) Authorizes Moderna's Omicron-containing Bivalent Booster in the UK
Moderna, Inc . (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Evonetix Commences Early Access Program for DNA Synthesised by Thermal Control on Its Semiconductor Chip
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]
GITAI Develops Inchworm-Type Robotic Arm Extending Both the Capability and Mobility of Space Robots and Completes Proof-of-Concept Demonstration (TRL 3)
GITAI USA Inc. (GITAI), the world’s leading space robotics company, developed the GITAI IN1 (Inchworm One), a […]
Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trial
Anixa Biosciences, Inc. (NASDAQ: ANIX) (“Anixa”) a biotechnology company focused on the treatment and prevention of cancer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more